- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-19-0171151

Hetairos Pharmaceuticals Private Limited
About Hetairos Pharmaceuticals Private Limited
Data last updated:
Hetairos Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medical appliances and instruments segment of the healthcare sector. It was incorporated on 18 January 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33119MH2022PTC375079.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jitendra Yadav and Varsha Suresh Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mmf 13 1/1 Bh Pritam Ceramics Nr. Neeldurg Hotel Mukti Nagar Chembur, Mumbai, Maharashtra, India – 400088.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.07 Lakh. For the same year it recorded a net loss of ₹3.18 Lakh (net margin -24.3%) and EBITDA of -₹3 Lakh (EBITDA margin -22.9%).
Hetairos Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0171151).
Company details
Recognitions & Rankings of Hetairos Pharmaceuticals
Contact details
Hetairos Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressMmf 13 1/1 Bh Pritam Ceramics Nr. Neeldurg Hotel Mukti Nagar Chembur, Mumbai, Maharashtra, India – 400088
- IndustryHealthcare, Medical Appliances And Instruments, Manufacturing, Medical & Surgical Equipment, Orthopedic Appliances, Other Medical And Surgical Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hetairos Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Hetairos Pharmaceuticals Private Limited, buy the company report.
Financials of Hetairos Pharmaceuticals Private Limited
FY 2025 filings availableHetairos Pharmaceuticals Private Limited reported revenue of ₹13.07 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹3 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹3.18 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -22.9% | ||
| Net Profit Margin | -24.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Hetairos Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hetairos Pharmaceuticals Private Limited
Hetairos Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitendra Yadav Also directs: Lifecura Pharma India Private Limited | Director | 18 Jan 2022 | 4 Years 9 Months | Current |
| Varsha Suresh Gupta | Additional Director | 02 Aug 2024 | 2 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Hetairos Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hetairos Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hetairos Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hetairos Pharmaceuticals Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Mubin Khan ceased to be Director on 21 Aug 2024.
Frequently asked questions
Hetairos Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical appliances and instruments, within the healthcare industry. It was incorporated on 18 January 2022 (4+ years old) and is registered under CIN U33119MH2022PTC375079.
Hetairos Pharmaceuticals has 2 current directors:
- Jitendra Yadav - Director
- Varsha Suresh Gupta - Additional Director
The latest financial statements of Hetairos Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Hetairos Pharmaceuticals is U33119MH2022PTC375079. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hetairos Pharmaceuticals was incorporated on 18 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Mubin Khan ceased to be Director on 21 Aug 2024. Varsha Suresh Gupta was appointed as Additional Director on 02 Aug 2024. Jitendra Yadav was appointed as Director on 18 Jan 2022.
Yes, Hetairos Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0171151).
The registered office of Hetairos Pharmaceuticals is at Mmf 13 11 Bh Pritam Ceramics Nr. Neeldurg Hotel Mukti Nagar Chembur, Mumbai, Maharashtra, India – 400088.
Hetairos Pharmaceuticals operates in the healthcare industry, in the medical appliances and instruments segment.
Hetairos Pharmaceuticals can be reached at its registered office: Mmf 13 11 Bh Pritam Ceramics Nr. Neeldurg Hotel Mukti Nagar Chembur, Mumbai, Maharashtra, India – 400088.

